Auxly Cannabis Group (TSXV:XLY) offered shareholders an update on the company’s operations in Uruguay through its partner Inverell.
As quoted in the press release:
Pursuant to the definitive agreement (the “Agreement”) dated April 10, 2018, the Company will acquire 80 [percent] of the outstanding common shares of Inverell in exchange for aggregate consideration of US$15 [million]. Part of the consideration is subject to Inverell achieving certain milestones related to the registration of certain cannabis genetics and the successful export of [cannabidiol] CBD products. The transaction remains subject to regulatory approval in Uruguay which the Company expects to receive imminently.
2018/2019 Cultivation Plan
Inverell has finalized its 2018/2019 cultivation plan where it will plant 150 hectares, composed of over 1,500,000 hemp plants, starting in mid-October 2018. Inverell’s land parcel contains key pieces of infrastructure needed for the mass cultivation of hemp plants, including a large fresh water lake that feeds into an existing irrigation system infrastructure. Inverell expects that the first harvest, once completed in April 2019, will yield approximately 75,000 kilograms of biomass to be used as feedstock for its extraction facility described below.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .